<< Back
Henry L. Nordhoff

Henry L. Nordhoff has been one of our directors since March 2005. He currently serves as Chairman and CEO of Banyan Biomarkers and has served as Executive Chairman of Cypher Genomics before the company was acquired by Human Longevity Inc. Mr.Nordhoff serves as Chairman of Chugai Pharma USA. He previously served as a director of BioTime, Inc. and of Asterias Biotherapeutics, Inc. Mr. Nordhoff retired as Chairman of the Board of Gen-Probe Incorporated, a clinical diagnostic and blood screening company, at the end of 2011, after serving as its Chairman since September 2002. He also served as Chief Executive Officer and President of Gen-Probe from July 1994 until May 2009. Prior to joining Gen-Probe, he was President and Chief Executive Officer of TargeTech, Inc., a gene therapy company that was merged into Immune Response Corporation. Prior to that, Mr. Nordhoff was at Pfizer, Inc. in senior positions in Brussels, Seoul, Tokyo and New York. He received a B.A. in international relations and political economy from Johns Hopkins University and an M.B.A. from Columbia University.


Copyright West LLC. Minimum 15 minutes delayed.

lib top


Learn more about MannKind's offices in the United States

Learn Morearrow

Lib bottom